Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination.
Joint Clinical Trials Office
Multimodal Neuroimaging in Traumatic Brain Injury
Study Status:
Open to Enrollment
Primary Investigator:
Date: February 16, 2021
Daratumumab, Pomalidomide and Dexamethasone (DPd) in Relapsed/Refractory Light Chain Amyloidosis Patients Previously Exposed to Daratumumab
Study Status:
Open to Enrollment
Primary Investigator:
Date: February 24, 2021
VMO-01C: An Open-Label, Multiple-Dose, Dose-Escalation Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of VMD-928 in Subjects with Solid Tumors or Lymphoma
Study Status:
Open to Enrollment
Primary Investigator:
Date: March 25, 2021
CSF Clearance in Sporadic Alzheimer’s Disease
Study Status:
Open to Enrollment
Primary Investigator:
Date: March 25, 2021
The Effects of Iron on Oxidative Stress and Alzheimer’s Disease Biomarkers in Amyloid-Positive and Negative Elderly Individuals
Study Status:
Open to Enrollment
Primary Investigator:
Date: March 25, 2021
Treatment of Newly Diagnosed Diffuse Anaplastic Wilms Tumors (DAWT) and Relapsed Favorable Histology Wilms Tumors (FHWT)
Study Status:
Open to Enrollment
Primary Investigator:
Date: April 1, 2021
PRagmatic EValuation of evENTs And Benefits of Lipid-lowering in oldEr Adults (PREVENTABLE)
Study Status:
Open to Enrollment
Primary Investigator:
Date: June 28, 2021
A Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Volixibat in the Treatment of Cholestatic Pruritus in Patients with Primary Sclerosing Cholangitis (VISTAS)
Study Status:
Open to Enrollment
Primary Investigator:
Date: July 7, 2021
A Phase I Clinical Trial of the Safety, Tolerability, and Efficacy of IL-15 Superagonist (N-803) With and Without Combination Broadly Neutralizing Antibodies to Induce HIV-1 Control During Analytic Treatment Interruption
Study Status:
Open to Enrollment
Primary Investigator:
Date: July 30, 2021
A Phase III Study to Evaluate Long-Acting Antiretroviral Therapy in Non-adherent HIV-Infected Individuals (The LATITUDE Study)
Study Status:
Open to Enrollment
Primary Investigator:
Date: August 10, 2021